Inactivation of 3-hydroxy-3-methylglutaryl coenzyme a reductase in cultured human blood mononuclear cells by procetofenic acid
Claudio Massaroli, Domenico Sommariva, Umberto Bortolini, Claudio Paolino, Angelo Fasoli, C Massaroli, D Sommariva, U Bortolini, C Paolino, A Fasoli
Index: Pharmacol. Res. Commun. 14(1) , 51-60, (1982)
Full Text: HTML
Abstract
The effect of procetofenic acid on 3-hydroxy-3-methylglutaryl Coenzyme A reductase (HMG-CoA reductase) activity has been studied on cultured human blood mononuclear cells. The drug produced a sharp decrease in enzyme activity both when it was added to the incubation medium and when it was added to the HMG-CoA reductase assay mixture. These findings strongly suggest that procetofenic acid inhibits HMG-CoA reductase activity by inactivating enzyme protein or by interfering with enzyme-substrate interaction. Since HMG-CoA reductase is a rate-limiting enzyme in cholesterol biosynthesis, its inhibition may explain, at least in part, the hypocholesterolemic effect of the drug.
Related Compounds
Related Articles:
Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis.
2015-02-01
[Biochim. Biophys. Acta 1851(2) , 231-7, (2015)]
2015-01-01
[J. Pharm. Pharm. Sci. 18(1) , 61-7, (2015)]
2015-02-27
[Biochem. Biophys. Res. Commun. 458(1) , 1-7, (2015)]
Effect of fenofibrate and LF 2151 on hepatic peroxisomes in hamsters.
1984-11-15
[Biochem. Pharmacol. 33(22) , 3661-6, (1984)]
1981-11-01
[Br. J. Pharmacol. 74(3) , 611-7, (1981)]